BioSpace News Archive

Policy

Vanda Pharmaceuticals, Inc. Announces Submission to FDA of a New Drug Application for Tasimelteon for the Treatment of Non-24-Hour Disorder in the Totally Blind

May 31, 2013
·
3 min read
Business

The Annual General Shareholders’ Meeting of Esaote S.p.A. Approved the Financial Statements for Financial Year Ending December 31st, 2012

May 31, 2013
·
1 min read
BioMidwest

Chronix Biomedical and University of Texas MD Anderson Cancer Center Release: Cell-Free DNA Accurately Correlates With Breast Cancer DNA

May 31, 2013
·
1 min read
Drug Development

Virttu Biologics U.S. Phase I Pediatric Study is Extended to Include Systemic Delivery of Oncolytic Virus

May 31, 2013
·
2 min read
BerGenBio AS Secures Additional $6 Million as First in Class AXL Kinase Inhibitor BGB324 Approaches Clinic

May 31, 2013
·
1 min read
Business

Biosensors International Enters Into Licensing Agreement With Eurocor for Drug-Eluting Balloon Range

May 31, 2013
·
2 min read
BioPartners GmbH Release: Positive CHMP Opinion for Once-Weekly Somatropin Biopartners

May 31, 2013
·
1 min read
BioIndustry Association’s UK CEO and Investor Forum Will Showcase Recent Deals and Fund Raisings

May 31, 2013
·
5 min read
Alkermes plc Presents Positive Results from Phase 2 Clinical Study of ALKS 5461 in Major Depressive Disorder at 53rd Annual NCDEU Meeting

May 31, 2013
·
1 min read
Genmab A/S Launches Sponsored Level 1 American Depositary Receipt (ADR) Program

May 31, 2013
·
1 min read